Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
UK Regulators Investigating Microsoft, Amazon
UK Regulators Investigating Microsoft, Amazon
McDonald's McRib is Coming Back
McDonald's McRib is coming back.
Apple Releases Patch to Fix iPhone 15 Overheating
Apple is releasing a fix to address overheating issues with the iPhone 15.
Clorox Blames Sales Drop on Cyberattack
Clorox blamed a recent cyberattack for a drop in sales and said it caused "widescale disruption" of operations.
Sam Bankman-Fried Fraud Trial Underway
Jury selection in the trial against FTX founder Sam Bankman-Fried has concluded and prosecutors have begun presenting their case.
CEW Beauty Awards Finalist Beia Beauty's Daily Hydrating and Intimacy Products
With the annual Beauty CEW Awards in tow, Brittany Lo, founder of Beia Beauty, joined Cheddar News to show and demonstrate some of her company's sensual care products. Beia Beauty is a finalist in the sexual wellness category.
Kaiser Permanente Strike Enters Second Day
The largest healthcare worker strike in U.S. history has entered its second day.
Stocks Fall Ahead of Friday Jobs Data
Stocks retreated in Thursday's session ahead of Friday's jobs data report.
Clorox Cyberattack to Drop Sales
Clorox Cyberattack to Drop Sales
